Andrew Reardon - 03 Sep 2026 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Reporting relationship: CLO & Secretary
Issuer ticker: LGND
Reported as of: 03 Sep 2026
Net transaction value: -$1,430,434
SEC form: 4
Accepted by SEC: 08 Sep 2026, 18:34:14 UTC
Prior SEC filing: 04 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Andrew Reardon

Key filing fact

Andrew Reardon filed Form 4 for LIGAND PHARMACEUTICALS INC (LGND) on 08 Sep 2026.

Key facts

This page summarizes Andrew Reardon's Form 4 filing for LIGAND PHARMACEUTICALS INC (LGND).
5 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 08 Sep 2026, 18:34.

Change

Previous filing in this sequence was filed on 04 Aug 2026.
Current net transaction value: -$1,430,434.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001950232 Primary reporting owner

Reardon Andrew

Relationship: CLO & Secretary
Address: 555 HERITAGE DRIVE, SUITE 200, JUPITER
Signature: /s/ Andrew Reardon
Signature date: 08 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LGND transaction

Common Stock

Sale

Transaction value: $85,196
Shares: -300
Change %: -0.72%
Price: $283.99
Shares after: 41,214
Date: 03 Sep 2026
Ownership: Direct
Footnotes: F1, F2

LGND transaction

Common Stock

Sale

Transaction value: $513,301
Shares: -1,800
Change %: -4.4%
Price: $285.17
Shares after: 39,414
Date: 03 Sep 2026
Ownership: Direct
Footnotes: F1, F3

LGND transaction

Common Stock

Sale

Transaction value: $605,649
Shares: -2,115
Change %: -5.4%
Price: $286.36
Shares after: 37,299
Date: 03 Sep 2026
Ownership: Direct
Footnotes: F1, F4

LGND transaction

Common Stock

Sale

Transaction value: $110,697
Shares: -385
Change %: -1%
Price: $287.53
Shares after: 36,914
Date: 03 Sep 2026
Ownership: Direct
Footnotes: F1, F5

LGND transaction

Common Stock

Sale

Transaction value: $115,592
Shares: -400
Change %: -1.1%
Price: $288.98
Shares after: 36,514
Date: 03 Sep 2026
Ownership: Direct
Footnotes: F1, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 04, 2026, in accordance with Rule 10b5-1.

Footnote F2

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $283.4300 to $284.1550. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $284.7500 to $285.7000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $285.8000 to $286.7700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F5

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $287.0500 to $287.6600. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F6

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $288.5500 to $289.4300. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.